The groundbreaking rise of Viagra has long been a symbol of pharmaceutical success, yet its legacy within the broader market now raises questions about future gains. Generic versions are undercutting market share, prompting concerns that betting on companies closely tied to Viagra's once-dominant influence could be a problematic strategy, especiall